Our study population displayed at least one characteristic of metabolic dysfunction (i.e., either hyperinsulinemia or glucose levels in the range of impaired fasting glucose or abnormal CRP levels) and are either overweight or obese. This evidence concerns the gene CRP and hyperinsulinism.